Matthews PM - Search Results

1

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.

Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Evangelou N, et al. Among authors: matthews pm. Ann Neurol. 2000 Mar;47(3):391-5. Ann Neurol. 2000. PMID: 10716264

2

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Arnold DL, et al. Among authors: matthews pm. Ann Neurol. 1992 Mar;31(3):235-41. doi: 10.1002/ana.410310302. Ann Neurol. 1992. PMID: 1637131

3

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Matthews PM, Francis G, Antel J, Arnold DL. Matthews PM, et al. Neurology. 1991 Aug;41(8):1251-6. doi: 10.1212/wnl.41.8.1251. Neurology. 1991. PMID: 1650931

4

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.

Arnold DL, Matthews PM, Francis G, Antel J. Arnold DL, et al. Among authors: matthews pm. Magn Reson Med. 1990 Apr;14(1):154-9. doi: 10.1002/mrm.1910140115. Magn Reson Med. 1990. PMID: 2161982

5

Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies.

Matthews PM, Arnold DL. Matthews PM, et al. Ann Neurol. 1990 Dec;28(6):839-40. doi: 10.1002/ana.410280620. Ann Neurol. 1990. PMID: 2285271 No abstract available.

6

Isolated capillary proliferation in Leigh's syndrome.

Matthews PM, Nagy Z, Brown GK, Land J, Squier MV. Matthews PM, et al. Clin Neuropathol. 1994 May-Jun;13(3):139-41. Clin Neuropathol. 1994. PMID: 7522140

7

Neurodevelopmental abnormalities and lactic acidosis in a girl with a 20-bp deletion in the X-linked pyruvate dehydrogenase E1 alpha subunit gene.

Matthews PM, Brown RM, Otero L, Marchington D, Leonard JV, Brown GK. Matthews PM, et al. Neurology. 1993 Oct;43(10):2025-30. doi: 10.1212/wnl.43.10.2025. Neurology. 1993. PMID: 7692352

8

Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders.

De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL. De Stefano N, et al. Among authors: matthews pm. Neurology. 1995 Jun;45(6):1193-8. doi: 10.1212/wnl.45.6.1193. Neurology. 1995. PMID: 7783888 Clinical Trial.

9

Mitochondrial abnormalities are not invariably present in neurologic syndromes associated with multiple symmetric lipomatosis.

Matthews PM, Squier MV, Chalk C, Donaghy M. Matthews PM, et al. Neurology. 1995 Jan;45(1):197-8. doi: 10.1212/wnl.45.1.197. Neurology. 1995. PMID: 7824120 No abstract available.

10

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP. Arnold DL, et al. Among authors: matthews pm. Ann Neurol. 1994 Jul;36(1):76-82. doi: 10.1002/ana.410360115. Ann Neurol. 1994. PMID: 8024266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results